Dextrose

Product NDC: 0409-4902
Requested package NDC: 0409-4902-34
11-digit product format: 004094902
Labeler code: 0409
Product ID: 0409-4902_2e27332e-01ed-4c16-8527-994199796ec0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: DEXTROSE MONOHYDRATE
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Hospira, Inc.
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2005-12-07
Marketing end: 0000-00-00
Substance: DEXTROSE MONOHYDRATE
Active strength: 25 g/50mL
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0409-4902	0409-4902-34	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 1 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0409-4902	0409-4902-34	D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2021-09-27	These highlights do not include all the information needed to use DEXTROSE INJECTION (50%) safely and effectively. See full prescribing information for DEXTROSE INJECTION (50%). DEXTROSE injection, for intravenous use Initial U.S. Approval: 1940
2021-09-27	These highlights do not include all the information needed to use DEXTROSE INJECTION (50%) safely and effectively. See full prescribing information for DEXTROSE INJECTION (50%). DEXTROSE injection, for intravenous use Initial U.S. Approval: 1940
2021-09-27	These highlights do not include all the information needed to use DEXTROSE INJECTION (50%) safely and effectively. See full prescribing information for DEXTROSE INJECTION (50%). DEXTROSE injection, for intravenous use Initial U.S. Approval: 1940
2021-09-27	These highlights do not include all the information needed to use DEXTROSE INJECTION (50%) safely and effectively. See full prescribing information for DEXTROSE INJECTION (50%). DEXTROSE injection, for intravenous use Initial U.S. Approval: 1940
2021-07-23	These highlights do not include all the information needed to use DEXTROSE INJECTION (50%) safely and effectively. See full prescribing information for DEXTROSE INJECTION (50%). DEXTROSE injection, for intravenous use Initial U.S. Approval: 1940
2021-07-23	These highlights do not include all the information needed to use DEXTROSE INJECTION (50%) safely and effectively. See full prescribing information for DEXTROSE INJECTION (50%). DEXTROSE injection, for intravenous use Initial U.S. Approval: 1940
2021-07-23	These highlights do not include all the information needed to use DEXTROSE INJECTION (50%) safely and effectively. See full prescribing information for DEXTROSE INJECTION (50%). DEXTROSE injection, for intravenous use Initial U.S. Approval: 1940
2021-07-23	These highlights do not include all the information needed to use DEXTROSE INJECTION (50%) safely and effectively. See full prescribing information for DEXTROSE INJECTION (50%). DEXTROSE injection, for intravenous use Initial U.S. Approval: 1940

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0409-4902-34	ML - Milliliter	0409-4902	b511e3b8-5d0e-47c4-9ea1-e72f55c2e441	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DEXTROSE MONOHYDRATE	ACTIVE INGREDIENT	LX22YL083G	DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.]	13
ANHYDROUS DEXTROSE	ACTIVE MOIETY	5SL0G7R0OK	DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.]	13
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.]	13
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.]	13
WATER	INACTIVE INGREDIENT	059QF0KO0R	DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.]	13
Dextrose Monohydrate	ACTIVE INGREDIENT	LX22YL083G	DEXTROSE INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC.]	2
Dextrose	ACTIVE MOIETY	IY9XDZ35W2	DEXTROSE INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-4902	DEXTROSE (DEXTROSE MONOHYDRATE) INJECTION, SOLUTION [HOSPIRA, INC.]	28	Legacy NDC	20250417_4ed365da-4e62-4329-c1b9-c197ab4fb6e1.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
LX22YL083G	DEXTROSE MONOHYDRATE	77938-63-7	DEXTROSE MONOHYDRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1795514	dextrose 50 % in 50 ML Injection	PSN	4ed365da-4e62-4329-c1b9-c197ab4fb6e1	32
727517	dextrose 50 % in 50 ML Prefilled Syringe	PSN	4ed365da-4e62-4329-c1b9-c197ab4fb6e1	32
1795514	50 ML glucose 500 MG/ML Injection	SCD	4ed365da-4e62-4329-c1b9-c197ab4fb6e1	32
727517	50 ML glucose 500 MG/ML Prefilled Syringe	SCD	4ed365da-4e62-4329-c1b9-c197ab4fb6e1	32
727517	50 ML dextrose 50 % Prefilled Syringe	SY	4ed365da-4e62-4329-c1b9-c197ab4fb6e1	32
727517	dextrose 25 GM per 50 ML Prefilled Syringe	SY	4ed365da-4e62-4329-c1b9-c197ab4fb6e1	32
1795514	dextrose 50 % per 50 ML Injection	SY	4ed365da-4e62-4329-c1b9-c197ab4fb6e1	32
727517	dextrose 50 % in 50 ML Prefilled Syringe	PSN	677bb6d6-704b-5be5-e053-2991aa0a5f6f	3
727517	dextrose 50 % in 50 ML Prefilled Syringe	PSN	9bd8168d-ab8f-4d70-e053-2995a90ac23c	3
727517	50 ML glucose 500 MG/ML Prefilled Syringe	SCD	677bb6d6-704b-5be5-e053-2991aa0a5f6f	3
727517	50 ML glucose 500 MG/ML Prefilled Syringe	SCD	9bd8168d-ab8f-4d70-e053-2995a90ac23c	3
727517	50 ML dextrose 50 % Prefilled Syringe	SY	677bb6d6-704b-5be5-e053-2991aa0a5f6f	3
727517	50 ML dextrose 50 % Prefilled Syringe	SY	9bd8168d-ab8f-4d70-e053-2995a90ac23c	3
727517	dextrose 25 GM per 50 ML Prefilled Syringe	SY	677bb6d6-704b-5be5-e053-2991aa0a5f6f	3
727517	dextrose 25 GM per 50 ML Prefilled Syringe	SY	9bd8168d-ab8f-4d70-e053-2995a90ac23c	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0409-4902-34	00409490234	10 CARTON in 1 CONTAINER (0409-4902-34) > 1 SYRINGE in 1 CARTON > 50 mL in 1 SYRINGE (0409-4902-64)	10 carton	2005-12-07	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Dextrose	Hospira, Inc.	2026-07-13	HUMAN PRESCRIPTION DRUG LABEL	34
50% Dextrose Injection, USP 25 grams (0.5g/ml)	Henry Schein, Inc.	2024-10-14	HUMAN PRESCRIPTION DRUG LABEL	4
50% Dextrose Injection, USP 25 grams (0.5g/ml)	General Injectables & Vaccines, Inc.	2022-12-19	HUMAN PRESCRIPTION DRUG LABEL	9
50% DEXTROSE INJECTION, USP 25 grams (0.5g/mL) 50mL SYR	HF Acquisition Co LLC, DBA HealthFirst	2022-12-10	HUMAN PRESCRIPTION DRUG LABEL	3
50% Dextrose Injection, USP	Medical Purchasing Solutions, LLC	2022-10-13	HUMAN PRESCRIPTION DRUG LABEL	3